The Canadian Pharmacists Association (CPhA) works closely with provincial and national pharmacy associations to provide a strong, unified voice for the profession in Canada. As pharmacists undertake an enhanced role in the delivery of health care services, CPhA ensures that the profession is recognized as a national leader in health care, influencing the policies, programs, budgets and initiatives affecting the profession and the health of Canadians.
National Voice: CPhA is the uniting national voice of pharmacy and the pharmacist profession in Canada. We communicate and engage with national decision-makers and health stakeholders on a regular basis to advance the voice of our members.
Thought-Leader: CPhA actively develops policies and positions and conducts research to advance the interests of the profession and role of the pharmacist within the health care system.
Image & Reputation: CPhA actively works to enhance the image and reputation of the profession by communicating the value of pharmacy services to the health care system and to the health of Canadians.
Recent Activities & Statements
As Canada's aging population strains health care system, Canadians eye pharmacists as potential solution
A new survey says Canadians regard the challenge of Canada’s aging population as a more serious issue than the rising cost of housing, climate change, income inequality or balancing the deficit, and they believe pharmacists should play a bigger role in sustaining a high-quality health care system.
CPhA welcomes federal budget commitments for further collaboration on key health issues
The Canadian Pharmacists Association welcomes many of the measures announced in the 2019 federal budget, including the important commitment to collaborate with health stakeholders, specifically on national pharmacare and a new national drug agency.
American and Canadian pharmacist associations warn that drug importation policies could put patients at risk
The American Pharmacists Association and Canadian Pharmacists Association have issued a joint statement opposing U.S. federal legislation authorizing personal and commercial importation of prescription drugs from Canada.